Axsome Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

액섬 테라퓨틱스NASDAQ:AXSM · Nasdaq · Healthcare

$179.25-1.55%

2026-10-02 close

Axsome Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $386M. 2024 operating profit was −$281M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy